Post Profile






Wistar scientists develop novel immunotherapy technology for prostate cancer

(The Wistar Institute) A study led by Wistar scientists describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer-specific protein.
read more

share

Related Posts


A novel DNA vaccine design improves chances of inducing anti-tumor immunity

Health : EurekAlert: Health

(The Wistar Institute) Scientists at The Wistar Institute and Inovio Pharmaceuticals, Inc. have devised a novel DNA vaccine approach through molecular design to improve the immune responses elicited against one of the most important...

Ludwig Cancer Research and the Cancer Research Institute Evaluate Immunotherapeutic Strategies for Brain Cancer and Other Types of Solid Tumors

Health : Newswise Medical News

Ludwig Cancer Research (Ludwig) and the Cancer Research Institute (CRI) have launched clinical trials evaluating an immunotherapy for the treatment of the brain cancer glioblastoma multiforme (GBM), and a combination of immunotherap...

Novel Vaccine Strategy Produces Rapid and Long-Term Protection Against Chikungunya Virus

Health : Newswise Medical News

Now, new research from The Wistar Institute has demonstrated how a novel vaccine strategy that boosts the immune system by rapidly producing antibodies against CHIKV, combined with a traditional DNA-based vaccine approach, can provi...

New DNA-based strategy shows promise against a range of influenza viruses

Academics / Chemistry : EurekAlert: Chemistry

(The Wistar Institute) A novel, DNA-based strategy to provide protection against an array of influenza viruses has been developed in preclinical models by scientists at Wistar, MedImmune and Inovio Pharmaceuticals, Inc. These study ...

Scientists develop novel immunotherapy technology for prostate cancer

Diseases & Conditions / Cancer : ScienceDaily: Cancer

A novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer-specific protein has been described in a new article.

Comments


Copyright © 2016 Regator, LLC